{"sourcedb":"DevicePMAs@therightstef","sourceid":"P950002_S012","text":"Approval to add the 9mm x 20mm bak vista interbody fusion device, which is manufactured from 65% peek optima and 35% toho besfight c6-uh carbon fiber, to the approved product line for the bak interbody fusion system.  The device will be marketed under the trade name bak vista interbody fusion device and is indicated for use with autogenous bone graft in patients with degenerative disc disease (ddd) at the l2-s1 levels.  These ddd patients may also have up to grade i spondylolisthesis or retrolisthesis at the involved level(s).  Bak devices are to be implanted via an open anterior or posterior approach.  Ddd is defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies.  These patients would be skeletally mature and have had six months of non-operative treatment.","project":"consensus_PMA_Age_Indications"}